1. Purpose of Treatment

I understand that I am being offered treatment with a GLP-1 receptor agonist medication (such as semaglutide, tirzepatide, or similar medication) for weight management and/or metabolic health under the care of Meagan Sullivan and Dr. Arnold Panzer.

GLP-1 medications work by:

* Regulating appetite
* Slowing gastric emptying
* Improving blood sugar control
* Supporting weight reduction

⸻

2. Potential Benefits

I understand potential benefits may include:

* Weight loss
* Reduced appetite and cravings
* Improved blood sugar levels
* Improved metabolic markers

Results vary by individual, and no specific outcome is guaranteed.

⸻

3. Possible Risks and Side Effects

I understand that possible side effects include, but are not limited to:

Common Side Effects

* Nausea
* Vomiting
* Diarrhea
* Constipation
* Abdominal discomfort
* Fatigue
* Injection site reactions

Less Common but Serious Risks

* Pancreatitis
* Gallbladder disease
* Kidney problems
* Severe gastrointestinal symptoms
* Allergic reactions
* Thyroid C-cell tumors (observed in animal studies; human risk unclear)

I understand I should seek medical attention immediately if I experience severe abdominal pain, persistent vomiting, signs of allergic reaction, or other concerning symptoms.

⸻

4. Contraindications

I confirm that I have informed my provider if I:

* Have a personal or family history of medullary thyroid carcinoma
* Have Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
* Have a history of pancreatitis
* Am pregnant, planning pregnancy, or breastfeeding
* Have severe gastrointestinal disease

⸻

5. Off-Label Use (If Applicable)

I understand that some GLP-1 medications may be prescribed off-label for weight management depending on my diagnosis and clinical evaluation. I have had the opportunity to ask questions regarding this use.

⸻

6. Treatment Expectations and Compliance

I understand that:

* GLP-1 therapy is most effective when combined with dietary changes, physical activity, and lifestyle modification
* I must follow dosing instructions carefully
* Missing doses or improper use may reduce effectiveness or increase risk
* Ongoing follow-up appointments and lab work may be required
* Discontinuation may result in weight regain

⸻

7. Financial Responsibility

I understand:

* The cost of treatment, including medication, visits, and labs
* Whether this medication is covered by my insurance
* That I am financially responsible for services not covered by insurance

⸻

8. Voluntary Consent

I acknowledge that:

* I have had the opportunity to ask questions
* My questions have been answered to my satisfaction
* I understand the risks, benefits, and alternatives
* I may withdraw consent at any time
* I voluntarily consent to receive GLP-1 injection therapy under the supervision of Meagan Sullivan and Dr. Arnold Panzer